T-cell receptor on tetanus toxoid-specific CD4+ T cells (TT-specific TCR)

The T-cell receptor (TCR) on tetanus toxoid-specific CD4+ T cells is a heterodimeric surface protein complex that specifically recognizes peptides derived from the tetanus toxoid (TT) protein when presented by Major Histocompatibility Complex (MHC) class II molecules (Meuer et al., 1983, Nature). This recognition event is the cornerstone of the secondary immune response to Clostridium tetani, leading to the activation and clonal expansion of memory T-helper cells (Geiger et al., 2009, Journal of Experimental Medicine). These receptors are characterized by their high affinity for TT epitopes, which allows for the rapid induction of cytokines such as IL-2 and IFN-gamma upon re-exposure to the antigen (Bacher et al., 2013, Journal of Immunology). In clinical research, these TCRs are frequently used as a gold standard for validating T-cell assays and monitoring the efficacy of vaccine platforms due to the high prevalence of TT-specific immunity in the general population (Rosendahl Huber et al., 2014, Clinical & Experimental Immunology). While not a traditional drug target for small molecules, these TCRs are increasingly relevant in the development of TCR-engineered T-cell therapies and as targets for antigen-specific immunotherapy (Sallusto et al., 2018, Nature Reviews Immunology). The primary interaction occurs with the tetanus toxoid antigen, which serves as the ligand that triggers the receptor's signaling pathway during vaccination.

Other names

Tetanus toxoid-specific T-cell receptorTT-TCRCD4+ TT-specific TCRTetanus-specific TCR

The TCR recognizes specific tetanus toxoid peptides presented by MHC Class II molecules, initiating a signaling cascade through the CD3 complex that leads to T-cell differentiation and memory formation.